DARUNAVIR 800 MG TABLET
For 30 tablets
Pharmacies pay
$71.46 filed
30 × $2.38195 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$722.87 filed
30 × $24.09579 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
10.1× estimated
Medicare paid 10.1× what pharmacies pay.
Part D averages every strength and form sold under “Darunavir” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$87.18 estimated
$71.46 + $10.72 (15%) + $5.00 fee per fill = $87.18
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
DARUNAVIR 800 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “darunavir” and “darunavir 800 mg”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “Darunavir 600 and 800 mg”.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 10 labelers (the companies named on the label) for its NDCs, among them Camber Pharmaceuticals, Inc., Dr.Reddys Laboratories Inc and Aurobindo Pharma Limited.
FDA’s Established Pharmacologic Class for it is Protease Inhibitor.
The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes); the FDA directory lists 10 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $71.46 for 30 tablets (30 × $2.38195 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 10 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| American Health Packaging | 1 | $2.38195 per EA filed |
| Amneal Pharmaceuticals NY LLC | 1 | $2.38195 per EA filed |
| Aurobindo Pharma Limited | 1 | $2.38195 per EA filed |
| Camber Pharmaceuticals, Inc. | 1 | $2.38195 per EA filed |
| Cipla USA Inc. | 1 | $2.38195 per EA filed |
| Dr.Reddys Laboratories Inc | 1 | $2.38195 per EA filed |
| EXELAN PHARMACEUTICALS INC. | 1 | $2.38195 per EA filed |
| Lupin Pharmaceuticals, Inc. | 1 | $2.38195 per EA filed |
| Novadoz Pharmaceuticals LLC | 1 | $2.38195 per EA filed |
| Viona Pharmaceuticals Inc | 1 | $2.38195 per EA filed |
| Not listed as a package in the FDA directory | 1 | $2.38195 per EA filed |
All 11 NDCs, with labeler and price
- 31722-0089-30 · Camber Pharmaceuticals, Inc. · $2.38195 per EA · eff. 2026-09-23 filed
- 43598-0705-30 · Dr.Reddys Laboratories Inc · $2.38195 per EA · eff. 2026-09-23 filed
- 59651-0086-30 · Aurobindo Pharma Limited · $2.38195 per EA · eff. 2026-09-23 filed
- 60219-1145-03 · Amneal Pharmaceuticals NY LLC · $2.38195 per EA · eff. 2026-09-23 filed
- 60687-0819-11 · not listed as a package in the FDA directory · $2.38195 per EA · eff. 2026-09-23 filed
- 60687-0819-21 · American Health Packaging · $2.38195 per EA · eff. 2026-09-23 filed
- 68180-0346-06 · Lupin Pharmaceuticals, Inc. · $2.38195 per EA · eff. 2026-09-23 filed
- 69097-0244-02 · Cipla USA Inc. · $2.38195 per EA · eff. 2026-09-23 filed
- 72205-0185-30 · Novadoz Pharmaceuticals LLC · $2.38195 per EA · eff. 2026-09-23 filed
- 72578-0148-06 · Viona Pharmaceuticals Inc · $2.38195 per EA · eff. 2026-09-23 filed
- 76282-0738-30 · EXELAN PHARMACEUTICALS INC. · $2.38195 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
3 other products in the NADAC file share an FDA nonproprietary name with DARUNAVIR 800 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| DARUNAVIR 600 MG TABLET | $1.16284 per EA filed | $24.09579 per EA filed |
| DARUNAVIR 800 MG TABLET this page | $2.38195 per EA filed | $24.09579 per EA filed |
| PREZISTA 600 MG TABLET | $34.89014 per EA filed | $53.74727 per EA filed |
| PREZISTA 800 MG TABLET | $70.10727 per EA filed | $53.74727 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 11 NDCs’ NADAC prices is $2.38195 per EA filed.
Of the 11 other products in FDA’s Protease Inhibitor class priced per EA, 7 have a higher middle NADAC price and 4 a lower one. The one in the middle is NORVIR 100 MG TABLET, at $8.3489 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $722.87 for 30 tablets, at an average of $24.09579 per EA in 2024 (2024-01-01 to 2024-12-31) for “Darunavir”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 51,231 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for DARUNAVIR 800 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Darunavir / Darunavir: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- PREZCOBIX 800 MG-150 MG TABLET
- SYMTUZA 800-150-200-10 MG TAB
- RITONAVIR 100 MG TABLET
- ATAZANAVIR SULFATE 200 MG CAP
- EVOTAZ 300 MG-150 MG TABLET